Reported Earlier, Anteris Secures German Regulatory Clearance To Expand PARADIGM Trial Comparing DurAVR THV With Commercial TAVRs Into Europe’s Largest TAVR Market
Share
Why It Matters
Anteris got permission to test its heart valve in Germany. This means the company can now reach more patients and prove its product works.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.